Introduction

In a decisive appellate ruling, the U.S. Court of Appeals for the Federal Circuit affirmed that multiple claims of Xilinx’s pipelined converter systems patent are unpatentable—delivering a significant win for Analog Devices, Inc. in a closely watched semiconductor IP dispute. Case No. 22-1612, filed April 11, 2022, and closed April 5, 2024, concluded after 725 days with the Federal Circuit upholding a finding of unpatentability based on a preponderance of the evidence standard.

The case centered on U.S. Patent No. 7,719,452 B2, covering “Pipelined converter systems with enhanced linearity”—technology directly relevant to analog-to-digital conversion architectures used across communications, industrial, and defense electronics. For patent attorneys tracking pipelined ADC patent litigation, IP professionals monitoring semiconductor IP strategy, and R&D teams assessing freedom-to-operate risk in converter system design, this outcome carries meaningful implications. The Federal Circuit’s affirmance reinforces PTAB’s invalidity findings and underscores ongoing vulnerability of foundational semiconductor patents to preponderance-based unpatentability challenges.

Case Overview

The Parties

The Patent at Issue

This case centered on a utility patent covering foundational technology in high-speed data acquisition systems. Utility patents are registered with the U.S. Patent and Trademark Office (USPTO) and protect functional inventions rather than ornamental appearance.

• • U.S. Patent No. 7,719,452 B2 — Pipelined converter systems with enhanced linearity.
• • Claims at Issue: Claims 1–4, 8, 9, 12–16, 19, and 20.

Pipelined analog-to-digital converters (ADCs) are foundational components in high-speed data acquisition systems. The ‘452 patent claimed innovations directed at improving linearity—a critical performance parameter—in multi-stage pipeline architectures. In plain terms, the patent addressed how successive conversion stages can be optimized to reduce error accumulation and improve signal fidelity.

The Accused Product(s)

The dispute involved Analog Devices’ pipelined converter system products alleged to practice the claimed linearity-enhancement techniques. The commercial importance of high-linearity ADC systems in defense, communications, and instrumentation markets elevated the competitive stakes of this litigation.

Legal Representation

Xilinx was represented by ArentFox Schiff LLP, with attorneys Janine A. Carlan, Jasjit S. Vidwan, and Taniel E. Anderson handling the appeal. Defendant representation details were not disclosed in available case records.

Litigation Timeline & Procedural History

The case reached the Federal Circuit as an appeal, indicating a prior proceeding—consistent with the USPTO’s Patent Trial and Appeal Board (PTAB) invalidity/cancellation action framework identified in the case data. The verdict cause is classified as an Invalidity/Cancellation Action, strongly suggesting this originated as an inter partes review (IPR) or post-grant proceeding before PTAB, with Xilinx appealing an adverse unpatentability determination to the Federal Circuit.

The 725-day appellate duration reflects the Federal Circuit’s standard briefing and adjudication cycle for complex patent validity appeals. The District of Columbia regional classification aligns with Federal Circuit jurisdiction, which hears all patent appeals nationally. No chief judge assignment was noted in available records.

The Verdict & Legal Analysis

Outcome

The Federal Circuit issued a clear and unambiguous ruling:

“ORDERED that, based on a preponderance of the evidence, claims 1–4, 8, 9, 12–16, 19, and 20 of the ‘452 patent have been shown to be unpatentable — AFFIRMED.”

Fourteen claims of U.S. Patent No. 7,719,452 B2 were invalidated. No damages were at issue in this appellate proceeding; the basis of termination is recorded as Unpatentable. No injunctive relief was implicated at this stage given the cancellation posture of the action.

Verdict Cause Analysis

The controlling legal standard—preponderance of the evidence—is the burden applied in USPTO post-grant proceedings under 35 U.S.C. § 316, as established by the America Invents Act (AIA). This is a lower evidentiary threshold than the “clear and convincing evidence” standard required to invalidate patents in district court litigation, which partially explains why PTAB and subsequent Federal Circuit review proceedings remain an attractive invalidity venue for accused infringers.

The unpatentability finding across 14 claims—spanning independent and dependent claims—suggests the invalidity challenge was broad and substantive, likely grounded in anticipation or obviousness under 35 U.S.C. §§ 102–103, though specific prior art references and expert testimony details are not disclosed in available case records. The Federal Circuit’s affirmance without apparent modification indicates strong deference to the underlying factual findings on unpatentability, consistent with the court’s application of the substantial evidence standard when reviewing PTAB factual determinations.

Legal Significance

This outcome carries several layers of legal significance:

1. Preponderance Standard Advantage: The affirmance reinforces why sophisticated defendants increasingly prefer IPR or post-grant review over district court invalidity defenses. The lower burden dramatically increases the probability of invalidating patents that might survive a district court challenge.

2. Claim Breadth Vulnerability: The invalidation of 14 claims—including multiple independent claims (1, 12, 19) and associated dependents—suggests the ‘452 patent’s core inventive concepts were susceptible to prior art attack. Patent prosecutors should note this as a reminder that broad claim portfolios without robust differentiation from prior art carry heightened PTAB risk.

3. Federal Circuit Deference: The affirmance reflects the Federal Circuit’s established deference to PTAB factual findings under the substantial evidence standard (Cuozzo Speed Technologies v. Lee, 579 U.S. 261 (2016)), making reversal of PTAB invalidity determinations statistically difficult for patent owners.

Industry & Competitive Implications

The semiconductor data conversion market—where Xilinx (AMD) and Analog Devices compete across FPGA-integrated and standalone converter products—is increasingly defined by signal chain integration and performance differentiation. The invalidation of the ‘452 patent removes a potential licensing or litigation leverage point from Xilinx’s portfolio in pipelined converter technology.

For Analog Devices, the outcome strengthens its IP freedom in high-linearity converter architectures and removes litigation uncertainty that could affect product roadmap decisions. ADI’s continued investment in precision ADC platforms—serving aerospace, defense, and 5G infrastructure markets—benefits directly from this cleared patent risk.

More broadly, this case reflects a continuing trend of semiconductor patent consolidation battles post-merger. Xilinx’s acquisition by AMD in 2022 elevated the strategic importance of protecting and monetizing Xilinx’s legacy IP portfolio. Unsuccessful patent assertions or validity challenges can accelerate portfolio rationalization decisions for acquiring companies integrating legacy IP assets.

The case also highlights the growing role of PTAB as the primary battleground for semiconductor patent validity disputes, with Federal Circuit appeals serving as a predictable final review stage with limited reversal rates for petitioner-favorable PTAB decisions.